Helen Scharfman Contributes to Study on Suppressing Epileptic Seizures

New York – Dr. Helen Scharfman, a research scientist at the Center for Dementia Research, contributed a perspectives piece to the March 20 issue of Science. The article, titled “Metabolic control of epilepsy,” became the subject of an interview by The Pharmaceutical Journal.  The research suggests that suggest that inhibition of LDH in mouse models could suppress seizures, making LDH a new target for a new group of antiepileptic drugs. This could replace the current difficult-to-follow ketogenic diet, a diet high in fats and low in carbohydrates.